Soleno Therapeutics Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

75.13

0.27 (0.36%)

At close: May 01, 2025, 3:59 PM

75.99

1.15%

Pre-market: May 02, 2025, 07:04 AM EDT

Soleno Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-175.85M	-38.99M	-24.07M	-30.91M	-24.64M	-30.77M	-11.84M	-12.07M	-12.07M
Depreciation & Amortization	1.99M	1.96M	1.96M	1.96M	1.95M	1.96M	1.96M	1.61M	131.64K
Stock-Based Compensation	99.96M	5.95M	2.53M	3.28M	1.5M	825K	988K	880.03K	871.27K
Other Working Capital	346K	1.56M	721K	-913K	1.48M	1.44M	-167K	-214.7K	-579.67K
Other Non-Cash Items	-1.21M	3.22M	-452K	-443K	4.62M	1.15M	1M	1.31M	-1.64M
Deferred Income Tax	n/a	n/a	n/a	-508K	-11.64M	6.96M	-3.88M	-1.65M	21.7K
Change in Working Capital	6.02M	2.93M	-756K	-1.15M	2.98M	2.5M	82K	-24.07K	-815.43K
Operating Cash Flow	-69.1M	-24.94M	-20.78M	-27.77M	-25.22M	-17.38M	-11.68M	-9.95M	-13.5M
Capital Expenditures	-218K	n/a	-13K	-22K	-7K	-21K	-8K	-2.57K	-38.68K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	500K	n/a	-572.59K	n/a
Purchase of Investments	-356.46M	n/a	n/a	n/a	n/a	-500K	n/a	n/a	n/a
Sales Maturities Of Investments	131M	n/a	n/a	n/a	n/a	500K	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	49K	-172K	953.94K	-23.89K
Investing Cash Flow	-225.68M	n/a	-13K	-22K	-7K	528K	-180K	378.78K	-38.68K
Debt Repayment	49.89M	n/a	n/a	-8K	-17K	-2K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-120	n/a	n/a	n/a	n/a	-7.78M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14.18M	42.16M	-16K	-120K	17K	n/a	1.52M	-838K	-1.39K
Financial Cash Flow	213.03M	180.02M	14.09M	-128K	53.72M	14.48M	17.83M	23.94M	10.77M
Net Cash Flow	-81.75M	155.08M	-6.7M	-27.92M	28.49M	-2.37M	5.96M	14.37M	-2.77M
Free Cash Flow	-69.31M	-24.94M	-20.79M	-27.79M	-25.23M	-17.4M	-11.69M	-9.95M	-13.54M